These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8797606)
1. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995. Butterworth BE Cancer Res; 1996 Sep; 56(18):4270-2; author reply 4272-4. PubMed ID: 8797606 [No Abstract] [Full Text] [Related]
2. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995. Cohen SM; Ellwein LB Cancer Res; 1996 Sep; 56(18):4269-70; author reply 4272-3. PubMed ID: 8797605 [No Abstract] [Full Text] [Related]
3. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995. Ames BN; Gold LS Cancer Res; 1996 Sep; 56(18):4267-9; author reply 4272-4. PubMed ID: 8797604 [No Abstract] [Full Text] [Related]
4. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995. Stemmermann GN; Noffsinger A; Fenoglio-Preiser CM Cancer Res; 1996 Sep; 56(18):4267; author reply 4272-4. PubMed ID: 8797603 [No Abstract] [Full Text] [Related]
5. Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Farber E Cancer Res; 1995 Sep; 55(17):3759-62. PubMed ID: 7641190 [No Abstract] [Full Text] [Related]
6. Correspondence Re: Farber E: Cell proliferation is not a major risk factor for cancer. Mod Pathol 9:606, 1996. Morris SA Mod Pathol; 1996 Nov; 9(11):1094-5. PubMed ID: 8933525 [No Abstract] [Full Text] [Related]
7. Correspondence Re: Farber E: Cell proliferation is not a major risk factor for cancer. Mod Pathol 9:606, 1996. O'Connell JT Mod Pathol; 1996 Nov; 9(11):1092-3. PubMed ID: 8933524 [No Abstract] [Full Text] [Related]
9. Cell hydration as the primary factor in carcinogenesis: A unifying concept. McIntyre GI Med Hypotheses; 2006; 66(3):518-26. PubMed ID: 16271440 [TBL] [Abstract][Full Text] [Related]
10. The instability of tumor promotion in relation to human cancer risk. Pitot HC; Dragan YP Prog Clin Biol Res; 1995; 391():21-38. PubMed ID: 8532718 [No Abstract] [Full Text] [Related]
11. Environmental and chemical carcinogenesis. Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140 [TBL] [Abstract][Full Text] [Related]
12. [Environmental carcinogens and p53 gene mutation]. Xu Z; Jin Y Wei Sheng Yan Jiu; 2004 Mar; 33(2):239-43. PubMed ID: 15209018 [TBL] [Abstract][Full Text] [Related]
13. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens. Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391 [TBL] [Abstract][Full Text] [Related]
14. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations]. Tubiana M Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515 [TBL] [Abstract][Full Text] [Related]
15. Cell proliferation is not a major risk factor for cancer. Farber E Mod Pathol; 1996 Jun; 9(6):606. PubMed ID: 8782195 [No Abstract] [Full Text] [Related]
16. Environment, cancer, and molecular epidemiology: air pollution. Moran EM J Environ Pathol Toxicol Oncol; 1996; 15(2-4):97-104. PubMed ID: 9216792 [TBL] [Abstract][Full Text] [Related]
17. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies]. Pavanello S; Clonfero E G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438 [TBL] [Abstract][Full Text] [Related]
18. Cell proliferation in liver of Mmh/Ogg1-deficient mice enhances mutation frequency because of the presence of 8-hydroxyguanine in DNA. Arai T; Kelly VP; Komoro K; Minowa O; Noda T; Nishimura S Cancer Res; 2003 Jul; 63(14):4287-92. PubMed ID: 12874039 [TBL] [Abstract][Full Text] [Related]
19. Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer. Sun A; Shanmugam I; Song J; Terranova PF; Thrasher JB; Li B Prostate; 2007 Jun; 67(9):976-88. PubMed ID: 17440966 [TBL] [Abstract][Full Text] [Related]
20. Chloroform mode of action: implications for cancer risk assessment. Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]